Promoter holding
64.27%
ML
Mankind Life Sciences Private Limited - Due diligence report
A 360° intelligence report on Mankind Life Sciences Private Limited: trust score, financial health, credit view, compliance, directors, grow…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Mankind Life Sciences Private Limited — 360° Intelligence Report
Generated from MCA filings & public records74/100
Trust Score
Moderate
Mankind Life Sciences Private Limited is assessed as Moderate with a Trust Score of 74/100. Mankind Life Sciences Private Limited is an active private limited indian non-government company incorporated in 2020, operating in the Pharma sector. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.
Report generated on 16 Aug 2026 from the latest processed filings. Mankind Life Sciences Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
74/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
93/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
70/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
60/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreCaution Indicated
40/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 3 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 60/100 Moderate
- Negative operating earnings - debt service depends on external support.
- No open charges - unencumbered balance sheet.
- Moderate gearing (D/E 38%).
- Working-capital cover adequate.
Charges position: 0 open (-) · 0 satisfied (-).
Compliance Score: 93/100 Low Risk
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Litigation present in 1 court forum(s).
- 21 active GST registration(s).
Legal cases on record (1)
05
Director Intelligence
Stability score: 40/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| ABHAY KUMAR SRIVASTAVA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| AKHLAS AHMED | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ANIL KUMAR TYAGI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Rahul Dua | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ANJU KUMARI JHA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| NAGA SANKARA SRINIVASA RAO SUNDARA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Vivek Aggarwal | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 7 directors on the board.
- NAGA SANKARA SRINIVASA RAO SUNDARA has DIN status "Deactivated due to non-filing of DIR-3 KYC".
- 3 director exit(s) in the last 3 years.
Director & KMP remuneration (FY 2023)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2023 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Mankind Pharma Limited
Subsidiaries
1
Group entities
1
Capital events
7 allotment(s) · 3 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Mankind Pharma Limited | Holding Company | 74.00% |
| Upakarma Ayurveda Private Limited | Subsidiary Company | 74.00% |
Key managerial personnel: Rahul Dua (CFO) · NAGA SANKARA SRINIVASA RAO SUNDARA (Whole-time director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 70 · Distress 65
Growth signals & trust indicators
Latest year revenue grew 1.42.
Asset base grew 2.1x - capacity expansion.
EPFO headcount growing - hiring signal.
Operating for 5 years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Losses deepening year-on-year.
3 director exits within 2 years.
1 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence79/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment71/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance record supports lending.
Investor view71/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 3 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management churn warrants questions.
09
MCA Filings & Events Timeline
Latest 15 events30 Sep 2025
Last AGM held
Annual general meeting
01 Aug 2025
Director ceased
SANJAY KOUL
23 Apr 2025
Director appointed
Vivek Aggarwal (Company Secretary)
31 Mar 2025
Latest balance sheet
Filed with ROC
29 Nov 2024
Director ceased
ASHISH MITTAL
29 Sep 2024
Director ceased
ANJU KUMARI JHA
30 Sep 2023
Director appointed
ANJU KUMARI JHA (Director)
10 May 2023
Director appointed
NAGA SANKARA SRINIVASA RAO SUNDARA (Whole-time director)
01 Dec 2022
Securities allotted
10000000 Preference Shares - 10.00 cr raised
21 Oct 2022
Securities allotted
7000000 Equity Shares - 7.00 cr raised
01 Oct 2022
Director appointed
Rahul Dua (CFO)
12 Jul 2022
Securities allotted
40000000 Preference Shares - 40.00 cr raised
31 Mar 2022
Share transfer (FY 2022)
3699.00000000 shares to MANKIND PHARMA LIMITED
Share transfer (FY 2022)
3500.00000000 shares to MANKIND PHARMA LIMITED
Share transfer (FY 2022)
2800.00000000 shares to MANKIND PHARMA LIMITED
10
Key Observations
Auto-generated from the data aboveDebt-to-equity stands at 24% - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
7 active director(s) / partner(s); review board churn before relying on management continuity.
21 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 1 subsidiary(ies) - assess on a consolidated basis.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 7 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Mahima Cotex Private Limited | U17121MP2003PTC015833 | Indore, Madhya Pradesh, India |
| Shree Vijay Aqua Feeds Private Limited | U15400AP2010PTC071211 | Vijayawada, Andhra Pradesh, India |
| Pitti Coal India Private Limited | U23209DL2021PTC390874 | Delhi, Delhi, India |
| Veekas Pipes Pvt Ltd | U26956GJ1994PTC022277 | Ahmedabad, Gujarat, India |
| Vadakkedath Industries Private Limited | U47211KL2005PTC018202 | Meenachil, Kerala, India |
| Jagrati Paper Private Limited | U74900WB2015PTC205582 | Kolkata, West Bengal, India |
| Vardhanam Agro Foods Private Limited | U15400MP2018PTC046884 | Gwalior, Madhya Pradesh, India |
| Salasar Diam Private Limited | U36912GJ2009PTC056750 | Surat, Gujarat, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Mankind Life Sciences Private Limited before audits and certifications: compliance score 93/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Mankind Life Sciences Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 60/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 70/100, margin trends, ownership structure and peer set for Mankind Life Sciences Private Limited - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 74/100, distress signals and MSME payment-delay disclosures - know whether Mankind Life Sciences Private Limited pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Mankind Life Sciences Private Limited - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Mankind Life Sciences Private Limited an active company?
Mankind Life Sciences Private Limited has MCA status “Active” with a compliance score of 93/100 (Low Risk).
Is Mankind Life Sciences Private Limited financially healthy?
Mankind Life Sciences Private Limited has a Financial Health Score of 70/100 (Moderate) based on its filed financial statements.
Should I do business with Mankind Life Sciences Private Limited?
Its overall Trust Score is 74/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Mankind Life Sciences Private Limited?
The ultimate holding entity is Mankind Pharma Limited. 7 active director(s) are on record.
Does Mankind Life Sciences Private Limited have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Mankind Life Sciences Private Limited up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 93/100 (Low Risk).
Is it risky to lend to Mankind Life Sciences Private Limited?
Its Credit Risk Score is 60/100 (Moderate). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
